Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Collegium Pharma (COLL)

Collegium Pharma (COLL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,054,042
  • Shares Outstanding, K 32,214
  • Annual Sales, $ 566,770 K
  • Annual Income, $ 48,160 K
  • EBIT $ 204 M
  • EBITDA $ 352 M
  • 60-Month Beta 0.95
  • Price/Sales 1.90
  • Price/Cash Flow 3.11
  • Price/Book 5.05

Options Overview Details

View History
  • Implied Volatility 68.52% ( -8.68%)
  • Historical Volatility 38.79%
  • IV Percentile 95%
  • IV Rank 74.38%
  • IV High 83.66% on 05/21/24
  • IV Low 24.53% on 12/08/23
  • Put/Call Vol Ratio 0.00
  • Today's Volume 2
  • Volume Avg (30-Day) 15
  • Put/Call OI Ratio 0.47
  • Today's Open Interest 1,014
  • Open Int (30-Day) 962

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/24
See More
  • Average Estimate 1.54
  • Number of Estimates 4
  • High Estimate 1.73
  • Low Estimate 1.41
  • Prior Year 1.21
  • Growth Rate Est. (year over year) +27.27%

Price Performance

See More
Period Period Low Period High Performance
1-Month
32.52 +1.88%
on 11/05/24
42.29 -21.65%
on 10/07/24
-8.73 (-20.86%)
since 10/04/24
3-Month
32.52 +1.88%
on 11/05/24
42.29 -21.65%
on 10/07/24
-1.39 (-4.03%)
since 08/05/24
52-Week
21.40 +54.81%
on 11/07/23
42.29 -21.65%
on 10/07/24
+10.93 (+49.23%)
since 11/03/23

Most Recent Stories

More News
Collegium to Report Third Quarter 2024 Financial Results on November 7, 2024

COLL : 33.26 (+1.65%)
Collingwood Closes Private Placement

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES

COLL : 33.26 (+1.65%)
Collingwood Announces Non-Brokered Private Placement and Board Appointment

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES

COLL : 33.26 (+1.65%)
Collegium Pharmaceutical: Q2 Earnings Snapshot

Collegium Pharmaceutical: Q2 Earnings Snapshot

COLL : 33.26 (+1.65%)
Collingwood Announces Director Resignation

VANCOUVER, BC / ACCESSWIRE / July 25, 2024 / Collingwood Resources Corporation (TSXV:COLL.P) (the "Company") announces that Jay Sujir has resigned from the Company's Board of Directors effective today....

COLL : 33.26 (+1.65%)
Sweetgreen, Natera rise; Collegium Pharmaceutical, Akamai fall, 5/10/2024

Stocks that traded heavily or had substantial price changes on Friday: Sweetgreen, Natera rise; Collegium Pharmaceutical, Akamai fall

DBX : 26.64 (+1.56%)
PGNY : 15.87 (+4.75%)
NTRA : 124.09 (+0.53%)
MTD : 1,380.59 (+1.21%)
AKAM : 100.66 (+0.62%)
COLL : 33.26 (+1.65%)
Collegium Pharmaceutical: Q1 Earnings Snapshot

Collegium Pharmaceutical: Q1 Earnings Snapshot

COLL : 33.26 (+1.65%)
Collegium Pharmaceutical: Q4 Earnings Snapshot

Collegium Pharmaceutical: Q4 Earnings Snapshot

COLL : 33.26 (+1.65%)
Collegium Pharmaceutical: Q3 Earnings Snapshot

Collegium Pharmaceutical: Q3 Earnings Snapshot

COLL : 33.26 (+1.65%)
A Little Known Strategy Indicates These Three Companies Could Explode!

In this article, we look at price action strategies and uncover three companies with the potential for a breakout.

VSEC : 105.93 (+2.85%)
BAH : 184.75 (+1.17%)
COLL : 33.26 (+1.65%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Sell with a Weakening short term outlook on maintaining the current direction.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Business Summary

Collegium Pharmaceutical Inc. is a specialty pharmaceutical company. It develops and commercializes prescription and over-the-counter pharmaceuticals for the treatment of central nervous system, respiratory and skin related disorders. The Company's product candidate consists of COL-195, COL-196, COL-171,...

See More

Key Turning Points

3rd Resistance Point 34.68
2nd Resistance Point 34.25
1st Resistance Point 33.49
Last Price 33.26
1st Support Level 32.29
2nd Support Level 31.86
3rd Support Level 31.10

See More

52-Week High 42.29
Fibonacci 61.8% 34.31
Last Price 33.26
Fibonacci 50% 31.84
Fibonacci 38.2% 29.38
52-Week Low 21.40

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar